Dean Schorno
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Rigel Pharmaceuticals Inc (RIGL) | Executive Vice President and Chief Financial Officer | $495,100 | $1,377,793 |
| 2023 | Rigel Pharmaceuticals Inc (RIGL) | Executive Vice President and Chief Financial Officer | $476,100 | $1,210,005 |
| 2022 | Rigel Pharmaceuticals Inc (RIGL) | Executive Vice President and Chief Financial Officer | $460,000 | $1,139,450 |
| 2020 | Rigel Pharmaceuticals Inc (RIGL) | Executive Vice President and Chief Financial Officer | $424,360 | $1,202,524 |
| 2019 | Rigel Pharmaceuticals Inc (RIGL) | Executive Vice President and Chief Financial Officer | $412,000 | $1,033,216 |
| 2018 | Rigel Pharmaceuticals Inc (RIGL) | Executive Vice President and Chief Financial Officer | $237,808 | $1,194,161 |
| 2017 | Rigel Pharmaceuticals Inc (RIGL) | Executive Vice President and Chief Financial Officer | — | — |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.